Venus Remedies Ltd.
BSE: 526953 | Sector: Health care |
NSE: VENUSREM | ISIN Code: INE411B01019 |
BSE 00:00 | 20 May | 243.50 |
2.60 (1.08%) |
OPEN
240.90 |
HIGH
249.00 |
LOW
240.90 |
NSE 00:00 | 20 May | 243.90 |
3.15 (1.31%) |
OPEN
249.00 |
HIGH
249.15 |
LOW
241.00 |
OPEN | 240.90 |
PREVIOUS CLOSE | 240.90 |
VOLUME | 4870 |
52-Week high | 638.50 |
52-Week low | 204.35 |
P/E | 5.03 |
Mkt Cap.(Rs cr) | 326 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Venus Remedies Ltd. (VENUSREM) - BULK DEALS
DATE | CLIENT NAME | EXCHANGE | TRANSACTION | QUANTITY | PRICE |
12-05-2022 | GUTTIKONDA RAJASEKHAR | NSE | SELL | 69399 | 211.46 |
27-10-2021 | XTX MARKETS LLP | NSE | SELL | 69468 | 561.89 |
27-10-2021 | XTX MARKETS LLP | NSE | BUY | 67949 | 558.99 |
09-08-2021 | GRAVITON RESEARCH CAPITAL LLP | NSE | SELL | 97760 | 616.96 |
09-08-2021 | GRAVITON RESEARCH CAPITAL LLP | NSE | BUY | 97760 | 616.58 |
06-08-2021 | GRAVITON RESEARCH CAPITAL LLP | NSE | BUY | 77756 | 549.69 |
06-08-2021 | GRAVITON RESEARCH CAPITAL LLP | NSE | SELL | 77756 | 548.99 |
25-06-2021 | AJAY UPADHYAYA | NSE | BUY | 75856 | 348.20 |
26-03-2021 | LAKSHMI GUTTIKONDA VARA | NSE | SELL | 65040 | 307.50 |
26-03-2021 | GUTTIKONDA RAJASEKHAR | NSE | BUY | 65040 | 307.50 |
27-08-2020 | KRISHNASWAMY MOHAN | NSE | SELL | 65977 | 101.78 |
27-08-2020 | KRISHNASWAMY MOHAN | NSE | SELL | 67000 | 103.25 |
04-05-2020 | ALPHA LEON ENTERPRISES LLP | NSE | BUY | 67638 | 53.75 |
04-05-2020 | ALPHA LEON ENTERPRISES LLP | NSE | SELL | 110451 | 53.85 |
17-10-2019 | CHAUDHARY AKSHANSH | NSE | BUY | 74332 | 29.74 |
16-10-2019 | IDBI BANK LIMITED | NSE | SELL | 67159 | 24.24 |
19-11-2018 | P ESWARAMOORTHY | NSE | SELL | 90607 | 57.69 |
19-11-2018 | P ESWARAMOORTHY | NSE | BUY | 7607 | 56.92 |
20-08-2018 | P ESWARAMOORTHY | NSE | SELL | 9553 | 56.40 |
20-08-2018 | P ESWARAMOORTHY | NSE | BUY | 64598 | 56.80 |
Quick Links for Venus Remedies:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices